Your trusted destination for CME, CPD & Medical Education across the Middle East.
Sidra Medicine, Doha, Qatar
Dr. Khalid Al Bureshad is a Qatar-based physician working in pediatric endocrinology and diabetes at Sidra Medicine in Doha. His documented professional affiliation is with the Division of Endocrinology, Department of Pediatric Medicine, Sidra Medicine, where his clinical and research work covers pediatric endocrine disorders, diabetes, thyroid disease, growth disorders, obesity and related metabolic conditions.
He is a faculty member of the Qatar Pediatric Endocrine and Diabetes Conference (QPEDC) 2026, where he is scheduled to present on when to refer a child with short stature to an endocrine clinic. This places his conference contribution within the pediatric growth and puberty component of the meeting.
Sidra Medicine, Doha, Qatar
Division: Endocrinology, Department of Pediatric Medicine
Professional field: Pediatric Endocrinology / Diabetes
His current Sidra affiliation is directly documented in a 2025 peer-reviewed case report, which lists him under the Division of Endocrinology, Department of Pediatric Medicine, Sidra Medicine, Doha, Qatar.
I could not locate a reliable current institutional page specifying his exact clinical grade (for example, Attending Physician or Specialist), so I would not assign a more specific job title without confirmation.
Dr. Al Bureshad's documented work is concentrated in pediatric endocrinology and diabetes, with research touching several endocrine conditions:
Sidra Medicine's pediatric endocrinology service covers growth and puberty disorders, thyroid disease, obesity, diabetes, hypoglycemia, adrenal and pituitary disorders, disorders of sexual differentiation, bone disorders and lipid disorders.
In 2025, Al Bureshad co-authored the case report:
“Permanent Congenital Hypothyroidism due to Rare Thyroglobulin Gene Variant (p.Cys1476Arg): A Delayed Diagnosis of Thyroid Dyshormonogenesis.”
The paper, published in Case Reports in Medicine, describes a Qatari child with congenital hypothyroidism who was subsequently found to have a homozygous thyroglobulin gene variant associated with thyroid dyshormonogenesis. The authors emphasized the importance of establishing the underlying cause of congenital hypothyroidism for long-term management and family counseling.
This publication is particularly relevant to his QPEDC role because it demonstrates his involvement in pediatric thyroid disease and genetic endocrine disorders.
Al Bureshad was also a co-author of research presented at the 62nd Annual European Society for Paediatric Endocrinology (ESPE) meeting in 2024 examining corneal nerve loss and regeneration in children with simple and monogenic obesity.
The study investigated children with obesity, including children with MC4R-related monogenic obesity, and examined changes in corneal nerve parameters following treatment with GLP-1 receptor agonists including liraglutide and semaglutide.
The study involved a multidisciplinary Sidra Medicine team and demonstrates his participation in research at the intersection of pediatric obesity, monogenic disease, diabetes/metabolism and emerging therapies.
His research group has also contributed to work involving Woodhouse-Sakati syndrome, a rare genetic disorder that can produce endocrine abnormalities including diabetes.
An ESPE 2024 abstract listed Al Bureshad among the authors of a study investigating diabetes mellitus in 18 Qatari patients with Woodhouse-Sakati syndrome.
Dr. Al Bureshad is listed among the faculty of the Qatar Pediatric Endocrine and Diabetes Conference 2026, organized by Sidra Medicine.
Conference: Qatar Pediatric Endocrine and Diabetes Conference – QPEDC 2026
Date: 27–28 November 2026
Location: Sidra Medicine Auditorium, Education City, Qatar
Role: Conference Faculty
Topic: “When to refer a child with short stature to an endocrine clinic”
His topic falls within the conference's Growth and Puberty Disorders module, which also covers evaluation of short stature, pubertal development and growth-hormone therapy.
He was also involved in the 62nd Annual European Society for Paediatric Endocrinology meeting in Liverpool, UK, in November 2024, where he was a co-author of research concerning obesity and corneal nerve changes in children.
Sidra Medicine
Sidra Medicine